chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day or two after shot had slight cold symptoms. Two days after shot had a fever of 103 and it lasted for a few days. Developed large lymph nodes at base of skull right before rash. Broke out in a rash a day or two later. First day of rash, was on the back of the neck. It was not a mild rash by any means. Following day rash worsened, bright red small dots all over body from head to toe. My daughter seemed to be slightly itchy. Doctor said it was not necessary to see her. I waited a day and when the rash worsened I brought her in anyway. They diagnosed her as having rubella which had been contagious. The nurse who had administered the injection and doctor told me that it was not necessary for them to report this to you. I am reporting it because of that.
Patient stated she had severe pain at time of injection. Then developed stiffness and a large (6x8in) black/blue bruising. She is a little swollen and finds her arm difficult to move. Will continue to ice and watch - will see MD if worsens. Came 3 days later.
Within 4 days of vaccine I started experiencing a significant headache, then started showing signs of vertigo.  By Thursday am full on Vertigo.  The vertigo was treated with Epley maneuver on 3/26.  I have continued to experience effects of vertigo through the time of my second Pfizer shot on 4/10.  Reporting on 4/13.  Vertigo lingering impacts still apparent but milder than anytime in the last 3 weeks.
I contracted COVID-19 on 06/09/2022 while traveling with symptoms of cough, fatigue but not more than normal during excursions, and only tested due to friend on trip becoming positive. I was not prescribed any medications. I had though these were allergy symptoms until my friend tested positive, due to the cold weather and grasses in the area. I was ill for 5 days before my symptoms resolved. I had a very mild case and have fully recovered with no lingering symptoms.
RETURNED TO DR OFFICE ON 2/24/2021 WITH RIGHT ARM PAIN, HURTS TO MOVE OR TOUCH THE RIGHT ARM. NO CELLUITIS.
The patient is a 26 year old male grad student, working in the vaccinia laboratory. He was vaccinated 17 days ago, and had a positive take. He subsequently developed a temperature to 100 and left axillary lymphadenopathy, but otherwise felt well. By post-vaccination day 12, the axillary nodes became so painful that he was evaluated daily for the next 5 days at the student health center. on post vaccination day 17, he presented to the hospital ER with a left axillary node that was fluctuant and the overlying skin was red. He was afebrile, felt generally well, but had a lacey reticular rash on his trunk on the same side as the inflamed lymph node. His CBC showed a WBC of 7,000, with no left shift. CT revealed a necrotic axillary node. The node was aspirated and the gram stain showed multiple polys with gram positive cocci in pairs. He was given Cefazolin and sent home on dicloxacillin, to follow up the next day. His temperature rose to 102 and the next day the lymph node was surgically debrided. Culture grew 3+ staph aureus. The patient is at home and doing well this morning. The rash resolved shortly after his first ER visit.
fever; possible secondary transmission of virus; This spontaneous report was received from Physician and refers to a 19-month-old of unknown gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 26-MAY-2023, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On 26-MAY-2023, the patient experienced possible secondary transmission of virus. On the same day, HCP states that the patient was visited by a relative (not a patient of HCP) the same day the patient was vaccinated. On 27-MAY-2023, the relative developed a rash the next day. On 28-MAY-2023, HCP states that the patient continues to have a fever today (HCP does not believe VARIVAX caused this). On the same day, by sunday relative was diagnosed with chickenpox. HCP believes the relative was not vaccinated. Limited information is available for this case as the HCP chose not to give full demographics and needed to end the call due to being in front of a patient. HCP states he is happy to follow up with any correspondence sent form. No Additional AE/PQC. At the time of reporting, the patient was recovering from the event of fever, the patient was recovering from the event of possible secondary transmission of virus. The action taken with varicella virus vaccine live (oka/merck) (VARIVAX) regarding fever was reported as Not Applicable. The action taken with varicella virus vaccine live (oka/merck) (VARIVAX) regarding possible secondary transmission of virus was reported as Not Applicable.   The reporter considered fever to be not related to varicella virus vaccine live (oka/merck) (VARIVAX). The causal relationship between possible secondary transmission of virus and varicella virus vaccine live (oka/merck) (VARIVAX) was unknown.
Lump on right upper thigh noted 1 week after 4 month immunizations. Seen 12/22/03 in office with pustule with erythematous base palpable fluctuant pea size mass with scab on roof.  Dry skin on chest and legs.  Diagnosed with cellulitis and eczema. Treated with Augmentin per mouth, Bactroban and warm soaks.  On 12/23/03 mom observed thick brown discharge erupting from pustule site.  Rechecked 12/26/03 diagnosed as resolving cellulitis.
The vaccine was at 9am and by 8pm I began having lower back pain. The pain progressed through the night staying mostly central and rated 6/10. I tried to sleep and woke up at 2 am with worsening lower back pain with pain into my flanks and hips bilaterally that was burning in nature and now rated an 8/10. The back pain and right flank pain persisted into the following day and evening. I woke at 3am on Monday morning and was drenched from sweating. At that time I noticed my back pain was 75% better. As I woke in the morning at 7am it was 80% better. I still have some residual central back and right flank pain but it is manageable. At a 3/10.
Slight redness on arm within 2 days of shot Larger  and brighter redness on arm, itchiness today, one week after vaccine Took oral Benadryl
This is a spontaneous report from a physician regarding a 17-year-old patient of unknown gender who received a dose of PROQUAD on 21-MAR-2017 and 23-MAY-2017 (lot # and expiration date not specified for either dose) for prophylaxis. No adverse event was reported.  Additional information has been requested.
Patient has had some swelling after 1st vax, 2nd vax has caused main problems with a metallic taste and burning in throat, later became lethargic, with some problems with memory and language.
The day after her 2nd dose on 4/18, she complained to me about severe leg pain in both legs
Uterus cramps, abdomen felt warm in the days following the vaccination, lower back pain, Delayed Period by 2 days. I track my cycle and have been regular with no cramping for 3 years. since being vaccinated, my period is heavier and the cramps are significantly worse  Also experienced sore throat for 4 days after the vaccination, and a headache.  Have had an overall unwell feeling since the vaccination
This is to report a breakthrough Covid infection.; This is to report a breakthrough Covid infection.; dose number=3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Nov2021 (Lot number: EW0187) at the age of 55 years as dose 3 (booster), single, administered in arm left, administration date 15Mar2021 (Lot number: EL3247) as dose 2, single and administered in arm left, administration date 22Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation.  The patient had no relevant medical history. There were no concomitant medications: no other medications in two-weeks. No other vaccine in four-weeks. The following information was reported: IMMUNISATION (medically significant) with onset 08Nov2021, outcome "unknown", described as "dose number=3"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04Jan2022, outcome "recovering" and all described as "This is to report a breakthrough Covid infection.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19. No follow-up attempts are possible. No further information is expected.
Area of induration, erythema formed on right thigh, firm/ fluctuant, seemingly nontender, no fever; firm area began in right thigh, became red after approximately 7 weeks on surface; 6 month vaccines received 5/7/21 and same reaction at Pediarix site on left thigh
omicron; It is made by your drug; omicron; It is made by your drug; truly messing with people RNA; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "omicron; It is made by your drug"; SUSPECTED COVID-19 (medically significant), outcome "unknown", described as "omicron; It is made by your drug"; ACQUIRED GENE MUTATION (medically significant), outcome "unknown", described as "truly messing with people RNA". No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
3/7 developed fever of 103.7 at around 11:30 PM. Right arm was swollen, red painful, hot. applied heating pad & herbal salve specific 4 trauma to skin  took a 500 mg Tylenol at around 12:30 AM. first time ever experienced chattering teeth. 3/8Woke next morning with 103.7 temp continued T/O the day & night. took 500 mg Tylenol 2x's. arm more red and swollen. Didn't feel ill. 3/9 fever of 101.5 , arm still swollen, red, painful.  3/10  fever of 101.1 took one Tylenol 3/11 no fever during day fever of 101.2 evening. More ice on swollen red painful and itchy arm 3/12 no fever during day up to 101.2 in the evening. 3/13 no fever. slept all day. 3/14 rested arm fine. No redness or swelling.
Patient experienced fever (unknown T-max) and arthralgias. Patient did not require medical care. Patient did have to take 1 sick day from work for recovery.
cold sweat; chills; Headache; Dizziness; Muscle pain; Mild shortness of breath; This is a spontaneous report from a non-contactable other healthcare professional. A 32-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) intramuscular at the left arm on 21Dec2020 10:00 AM at single dose for COVID-19 immunization. Medical history included sulfa allergies, depression and von willebrand's bleeding disorder. The patient had Covid prior to vaccination. The patient was not Covid tested post vaccination. Concomitant medications included fluoxetine, bupropion, montelukast, cetirizine and esomeprazole; all from unspecified date for unspecified indication. The patient had no other vaccine in four weeks. On 21Dec2020 10:00 AM, the patient experienced cold sweat, chills, headache, dizziness, muscle pain, mild shortness of breath. The outcome of the events cold sweat, chills, headache, dizziness, muscle pain, mild shortness of breath was recovering. The reporter considered the events non-serious.  No follow-up attempts are possible. Information about lot/Batch number cannot be obtained. No further information is expected.
When the pharmacist performed the injection at this clinic, I was watching the syringe at the injection site (arm), and noticed that something seemed off about the procedure. However, I did not say anything to the pharmacist in the moment. The pharmacist followed up on 11/28/21, noting, "We were going over the doses given on Wednesday and found that a few syringes on Wednesday were accidentally brought out to the tables before being filled. Before I went outside I grabbed two syringes from the tables inside and went to vaccinate your boys. I clearly fulling [sic] giving the dose to [younger son]. But with patient moving so much I don't remember pushing the plunger down. I thought at the time that I had just done it quickly, but later found out about the few syringes that were empty." We thanked the pharmacist for her honesty and discussed the situation with (at her recommendation) our pediatrician, who also was able to connect with the CDC's emergency operations center. Because the pharmacist and I both felt certain that the dose had not been administered, we opted to have her re-administer the shot at the same clinic location on 11/28/21.
Got the first and second doses in March and mentions may have gotten them one week apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the first and second doses in March and mentions may have gotten them one week apart) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the first and second doses in March and mentions may have gotten them one week apart). In March 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got the first and second doses in March and mentions may have gotten them one week apart) had resolved.            No concomitant medication were reported. No  treatment information was provided by the reporter. Patient took  Moderna COVID-19 booster dose on 29Oct2021 in his left deltoid muscle.   This case was linked to MOD-2021-374194 (Patient Link).
Family member got pregnant after receiving the 1st dose of Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Family member got pregnant after receiving the 1st dose of Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 30-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Family member got pregnant after receiving the 1st dose of Moderna vaccine). On 30-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Family member got pregnant after receiving the 1st dose of Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient got pregnant after receiving the first dose of vaccine. The second dose of Moderna vaccine was due on 27-Apr-2021.   No treatment of events was reported. No concomitant medications were reported.
Tingling and numbness in my tongue; Tingling and numbness in my tongue; Left side of my jaw is painful and it hurts to open my mouth; Frequent headaches; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 05May2021 at 08:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes in maternal grandfather and breast cancer in maternal grandmother. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol / levonorgestrel (LARISSIA) for birth control from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 08:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:00, on the day of the second vaccine, the patient noticed tingling and numbness in the tongue. The patient noticed it first in maybe an hour after the shot and it remained numb and tingly for about 4-5 hours. It had since gone away, but left side of the jaw was painful, it was hurting when tried to open the mouth and had frequent headaches which the patient thought those were coming from the jaw pain. On the day of reporting, it had been 5 days since the shot and the patient still had jaw pain and was planning to see a doctor if there was no relief from the pain in the next few days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and numbness in the tongue were resolved on 05May2021; while that of the events left side of the jaw was painful and it hurts to open the mouth and frequent headaches were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient feel pain, hardness and redness in the right arm where the Prevnar 13 vaccine was administered. Patient feel the symptoms since 10/06/2019. She visited Dr. for a previously scheduled appointment and she noticed the symptoms to the Doctor. Dr. contacted me today 10/11/2019 to inform the redness. I asked for the treatment the patient will received and Dr. said not treatment needed at this moment. She will see patient next week.
p/recv vax pt later that day devel a fever of 101.5f and vomiting;
problems walking; problems talking; balance off; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (problems walking), SPEECH DISORDER (problems talking), BALANCE DISORDER (balance off) and DIZZINESS (dizzy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced GAIT DISTURBANCE (problems walking), SPEECH DISORDER (problems talking), BALANCE DISORDER (balance off) and DIZZINESS (dizzy). At the time of the report, GAIT DISTURBANCE (problems walking), SPEECH DISORDER (problems talking), BALANCE DISORDER (balance off) and DIZZINESS (dizzy) outcome was unknown. Not Provided          Patient said She didn't work, went to the ER , but they said couldn't help her. She had a call into her doctor.   No concomitant information was reported.  No treatment information was reported.
Patient presented to the outreach booth at the downtown transfer center reporting a desire to be vaccinated for COVID. Reported he had not had COVID vaccine yet, answered no to the screening questions. Mobile harm reduction outreach event did not have a way to check records prior to vaccination. When his record was pulled up later at the office to document his vaccine, it showed a first dose of Pfizer given 30 days prior.
Breakthrough case admission after two vaccines, Pfizer 3/8/21 Lot# EN6199; Pfizer 3/29/21 Lot# ER8733.
No adverse reactions, a moderna that was out and punctured for over 24 hours was given.
PT REPORTED ON 1/18/2021 TO ME THAT SHE STILL HAD MUSCLE PAIN IN THE LEFT DELTOID WHERE THE FLUZONE HD WAS GIVEN ON 10/20/2020.  SHE ALSO HAS LIMITED RANGE OF MOTION IN THAT ARM & OCCASIONALLY HAS A SHOOTING NERVE PAIN DOWN HER ARM TO HER WRIST.    SHE DID NOT LET ME (PHARMACIST WHO GAVE HER THE IMZ) KNOW UNTIL 1/18/2021 BECAUSE SHE WANTED TO GIVE IT TIME TO SELF-RESOLVE.  NO TREATMENT WAS PURSUED BY PT.
Initial unsolicited report received from a physician on 24 Oct 2016. This case involves a 73-year-old female patient who was vaccinated with a dose of Fluzone HD (Batch number: UI642AA, expiry date: 03 Apr 2017, dose and dose series was not reported) via intramuscular route in the left deltoid on 26 Sep 2016. Patient's was allergic to PCN. Medical history includes hypertension and high cholesterol. Illness at time of vaccination was reported as no. It was reported that, the patient had no history of seizures. Concomitant medication was not reported. On 26 Sep 2016 (by the evening), same day following the vaccination, the patient had experienced a petit mal seizure (lasting a few second), lost control of bladder during seizure and was very sleepy afterwards. Patient required ER or doctor visit. Lab data and corrective treatment was not reported. On an unspecified date, the patient was recovered from the events. Upon internal review, the company decided to consider the event serious because of important medical event petit mal seizure. List of documents held by sender: none. Sender's Comments: This case concerns a 73 year old female patient who developed petit mal seizure on the same day after receiving INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. Time to onset is compatible with the role of the vaccine. Further information on the patient's previous immunization history, concurrent conditions, detailed medical history and lab data to confirm alternative etiology/diagnosis etc. will be needed to completely assess this case. Based on the available information, a role of the vaccine cannot be ruled out.
This spontaneous report was received from an other health professional refers to plenty of patients of unknown age. The health care professional mentioned that plenty of patients had fainted from being administered a dose of GARDASIL on an unknown day. It was unknown if the patients sought medical attention. The outcome of fainted was unknown. Additional information is not expected.
This is a two month old child brought in via EMS after what sounds like a febrile seizure at home. Mother said that the child had gotten four immunizations today. She had a fever of 101.5 prior to her seizure. She was given some Tylenol, put down on the couch, and approximately an hour prior to arrival, she had what appeared to be an episode of arm and leg shaking that lasted for approximately a minute with eyes rolling in the back of her head. No loss of color. No loss of spontaneous breathing. It was immediately subsided. The child was immediately alert and interactive according to Mom. There was no apparent postictal phase. EMS was called, and they transported the child there. On arrival here, the temperature is 99.1. Vital signs otherwise normal.